Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register July 6, 2026. Document 2026-13580. Updated Nov. 8, 2026.
- What it does
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine above a specified threshold, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 7-hydroxymitragynine above a specified threshold.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What it would change
1 part of Title 21 of the Code of Federal Regulations:
- What happens next and when
July 6, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-13580 |
|---|---|
| Action | Proposed amendment; notice of intent. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | July 6, 2026 |
| Docket | DEA-2026-1190 |
Source: the Federal Register (public domain). The document in the Federal Register